MedPath
TGA Approval

MOXIFLOXACIN APO moxifloxacin (as hydrochloride monohydrate) 400 mg tablet blister pack (309824)

309824

MOXIFLOXACIN APO moxifloxacin (as hydrochloride monohydrate) 400 mg tablet blister pack

Arrotex Pharmaceuticals Pty Ltd

August 9, 2019

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-CMI-01556-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2022-PI-01555-1

Active Ingredients

moxifloxacin hydrochloride monohydrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MOXIFLOXACIN APO moxifloxacin (as hydrochloride monohydrate) 400 mg tablet blister pack (309824) - TGA 批准文号 | MedPath